C07C 243/34
To carbon atoms of a carbon skeleton further substituted by nitrogen atoms
Official title: to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
C07C243/34 (To carbon atoms of a carbon skeleton further substituted by nitrogen atoms) appears on 87 US grants and 60 published applications in this corpus.
Search patents in C07C- Granted patents
- 87
- Published applications
- 60
- Assignees
- 50
- Inventors
- 256
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 0 |
| 2002 | 1 | 4 |
| 2003 | 3 | 1 |
| 2004 | 0 | 5 |
| 2005 | 2 | 0 |
| 2006 | 1 | 3 |
| 2007 | 2 | 0 |
| 2008 | 0 | 2 |
| 2009 | 1 | 0 |
| 2010 | 2 | 6 |
| 2011 | 1 | 2 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 4 | 6 |
| 2015 | 3 | 3 |
| 2016 | 4 | 3 |
| 2017 | 6 | 6 |
| 2018 | 0 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 3 |
| 2022 | 1 | 4 |
| 2023 | 2 | 3 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- L-DOPA and/or DOPA decarboxylse inhibitors conjugated to sugar for the treatment of dopamine-responsive disorders27 Jan 2026US 12,533,417 B2B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- Eco-friendly materials and methods for renewable and sustainable applications in material chemistry21 Jan 2025US 12,202,806 B2NDSU Research Foundation
- Aminocarbamoyl compounds for the treatment of viral infections13 Aug 2024US 12,060,333 B2Hoffmann-La Roche Inc.
- Compounds for the treatment of neurological or mitochondrial diseases3 Oct 2023US 11,771,685 B2MUSC Foundation for Research Development
- Compounds for the treatment of neurological or mitochondrial diseases8 Feb 2024US 2024/0041849 A1MUSC Foundation for Research Development
- Compounds for treating infections2 Nov 2023US 2023/0348365 A1Horitzonts Tecnologics Hungary KorláTolt FelelosséGu TáRsasáG
- Asparagine derivatives and methods of using same27 Jul 2023US 2023/0234917 A1
- Reagent for mass spectrometry25 May 2023US 2023/0160904 A1Roche Diagnostics Operations, Inc.
- Compounds for the treatment of paramyxovirus viral infections15 Dec 2022US 2022/0396581 A1Janssen BioPharma, Inc.
Most cited
By later US patents
- Functionalized ionic liquids, and methods of use thereof64US 7,208,605 B2University of South Alabama · 2007
- Aminobutyric acid derivatives49US 6,420,427 B1Ono Pharmaceutical Co., Ltd. · 2002
- Angiotensin converting enzyme inhibitors and their formulation and use as pharmaceuticals48US 4,748,160 AFisons Limited · 1988
- Hydrazide compounds44US 6,172,108 B2Adir et Compagnie · 2001
- Azaaspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors29US 5,565,430 ASterling Winthrop Inc. · 1996